Clinical Trial Update: Effects of Varenicline in Heavy Drinking Smokers [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating varenicline in heavy-drinking smokers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Tobacco Use Disorder

Drugs mentioned

• CHANTIX (varenicline tartrate)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Cigarette Smoking, Alcohol Consumption | Phase 4 | Status: WITHDRAWN